mesothelioma

Objective Malignant mesothelioma is a mesothelium-derived carcinoma with high malignancy.

Palliative procedures of mesothelioma treatment are known as Pleurectomy.

Mesothelioma and lung cancer are completely different diseases, with different origin sites, tumor structure and treatability.

Mesothelioma is a type of cancer that affects the mesothelium.

Exposure to asbestos is a major risk factor for developing mesothelioma.

Symptoms of mesothelioma may not appear until decades after exposure to asbestos.

Treatment for mesothelioma often involves a combination of surgery, chemotherapy, and radiation therapy.

Prognosis for mesothelioma is often poor due to its aggressive nature and late-stage diagnosis.

Mesothelioma cases have been on the rise in recent years due to past asbestos exposure.

Early detection of mesothelioma can lead to more treatment options and better outcomes.

Support groups can provide emotional and practical assistance to those affected by mesothelioma.

Mesothelioma lawsuits have been filed by individuals seeking compensation for asbestos-related illnesses.

Research into new treatments for mesothelioma is ongoing to improve patient outcomes.